Jeffrey L. Cummings

Research interests

Publications

• Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

  The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00066-1

• The Amyloid-β Pathway in Alzheimer’s Disease

  Molecular Psychiatry · 2021 · https://doi.org/10.1038/s41380-021-01249-0

• A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

  Alzheimer s Research & Therapy · 2021 · https://doi.org/10.1186/s13195-021-00813-8

• Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

  New England Journal of Medicine · 2019 · 10.1056/nejmoa1812840

• Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1706441

• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

  Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.02.002

• Alzheimer's disease

  Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.56

• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

  The Lancet Neurology · 2014 · 10.1016/s1474-4422(14)70090-0

• Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

  Alzheimer s Research & Therapy · 2014 · 10.1186/alzrt269

• Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

  Nature Genetics · 2011 · 10.1038/ng.801

• Revising the definition of Alzheimer's disease: a new lexicon

  The Lancet Neurology · 2010 · 10.1016/s1474-4422(10)70223-4

• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

  Nature Genetics · 2010 · 10.1038/ng.536

• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  Movement Disorders · 2007 · 10.1002/mds.21507

• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

  The Lancet Neurology · 2007 · https://doi.org/10.1016/s1474-4422(07)70178-3

• Mild cognitive impairment

  The Lancet · 2006 · 10.1016/s0140-6736(06)68542-5

• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  Journal of the American Geriatrics Society · 2005 · https://doi.org/10.1111/j.1532-5415.2005.53221.x

• Alzheimer's Disease

  New England Journal of Medicine · 2004 · 10.1056/nejmra040223

• Frontal–subcortical neuronal circuits and clinical neuropsychiatry

  Journal of Psychosomatic Research · 2002 · 10.1016/s0022-3999(02)00428-2

• Practice parameter: Diagnosis of dementia (an evidence-based review)

  Neurology · 2001 · 10.1212/wnl.56.9.1143

• Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]

  Neurology · 2001 · 10.1212/wnl.56.9.1133

• Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

  Neurology · 2001 · 10.1212/wnl.56.9.1154

• Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory

  Journal of Neuropsychiatry · 2000 · 10.1176/jnp.12.2.233

• Frontotemporal lobar degeneration

  Neurology · 1998 · https://doi.org/10.1212/wnl.51.6.1546

• The Neuropsychiatric Inventory

  Neurology · 1994 · https://doi.org/10.1212/wnl.44.12.2308

• Frontal-Subcortical Circuits and Human Behavior

  Archives of Neurology · 1993 · 10.1001/archneur.1993.00540080076020

• Vascular dementia

  Neurology · 1993 · https://doi.org/10.1212/wnl.43.2.250

Current projects

No projects listed.